People_

Professor Luis Vitetta

Adjunct Professor
Sydney School of Pharmacy
Faculty of Medicine and Health

Email

luis.vitetta@sydney.edu.au

Websites

Resume

Clinical epidemiology / The human microbiome / Probiotics and Prebiotics and Mood Disorders / Cellular redox potential and pro-oxidant signaling systems

Teaching and supervision

Epidemiology - Clinical Trials / Clinical Problem Based Learning / Microbiology / Nutritional Biochemistry / Physiology /

Current projects

RHD COMPLETED: Talia PALACIOS CAMPANA

Research Project Title: The Effect of a Multi-strain Probiotic on Metabolic Biomarkers in Pre-diabetic Adults

The intestinal microbiome and chronic kidney disease.

Cannabis for intractable pain and chemotherapy induced nausea and vomiting.

Associations

Editorial Board Memberships

World Journal of Gastrointestinal Pharmacology and Therapeutics [2017 - 2020]

Journal of World Mitochondria Society [2015 - onging]

Inflammopharmacology [2014 - ongoing]

Journal of Controversies in Biomedical Research [2014 - 2019]

Advances in Integrative Medicine [2013 - 2018]

BMC Complementary and Alternative Medicine [2013 - ongoing]

Journal of Complementary Medicine [2008 - 2012]

Jourmnal of Functional Foods [2020 - ongoing]

Scientific Advisory Boards

Journal of Molecular Pathophysiology

Themes

Obesity, Diabetes and Cardiovascular Disease, Infection and Immunological Conditions

Keywords

Biochemistry, Immunology, Nutrition and metabolism, Pharmacology

Approaches

Adult, Cellular/Molecular, Clinical Trials

Clinical speciality

Gastroenterology and Hepatology

Current research students

Project title	Research student
Effects of Extra Virgin Olive Oil on Ulcerative Colitis	Kenneth DANIEL
Pulmonary delivery of probiotic formulations in respiratory infections	Grace YAU

Publications

By Type

Expand all

Book Chapters

Vitetta, L., Palacios, T., Hall, S., Coulson, S. (2015). Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End-Organ Physiology. In K D Rainsford, M C Powanda, M W Whitehouse (Eds.), Novel Natural Products:Therapeutic Effects in Pain, Arthritis and Gastro-intestinal Diseases, (pp. 1-33). Basel: Springer. [More Information]
Coulson, S., Palacios, T., Vitetta, L. (2015). Perna canaliculus (Green-Lipped Mussel): Bioactive Components and Therapeutic Evaluation for Chronic Health Conditions. In K D Rainsford, M C Powanda, M W Whitehouse (Eds.), Novel Natural Products:Therapeutic Effects in Pain, Arthritis and Gastro-intestinal Diseases, (pp. 91-132). Basel: Springer. [More Information]

Journals

Thomsen, M., Vemuri, R., Huygens, F., Clarke, S., Vitetta, L. (2024). An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid. Inflammopharmacology. [More Information]
Vitetta, L., Henson, J. (2024). Comment on “Hall et al., Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain”. Journal of Cannabis Research, 6(1), 13. [More Information]
Vitetta, L., Oldfield, D., Sali, A. (2024). Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods. Frontiers in Bioscience, 16(2). [More Information]
Strodl, E., Bambling, M., Parnam, S., Ritchie, G., Cramb, S., Vitetta, L. (2024). Probiotics and magnesium orotate for the treatment of major depressive disorder: a randomised double blind controlled trial. Scientific Reports, 14(1), 20841. [More Information]
Ritchie, G., Strodl, E., Parham, S., Bambling, M., Cramb, S., Vitetta, L. (2023). An exploratory study of the gut microbiota in major depression with anxious distress. Journal of Affective Disorders, 320, 595-604. [More Information]
Chen, J., Vitetta, L. (2023). Is miR-223 Upregulation in Inflammatory Bowel Diseases a Protective Response? Frontiers in Bioscience, 15(1). [More Information]
Vitetta, L. (2023). Letter on “Role of gut microbiome in immune regulation and immune checkpoint therapy of colorectal cancer”. Medical Oncology: a leading journal in clinical oncology, 40(5), 143. [More Information]
Vitetta, L., Gorgani, N., Vitetta, G., Henson, J. (2023). Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus. Biomolecules, 13(9), 1307. [More Information]
Vitetta, L., Bambling, M., Strodl, E. (2023). Probiotics and Commensal Bacteria Metabolites Trigger Epigenetic Changes in the Gut and Influence Beneficial Mood Dispositions. Microorganisms, 11(5). [More Information]
Pickering, E., Steels, E., Steadman, K., Rao, A., Vitetta, L. (2022). A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain. Inflammopharmacology, 30(6), 2063-2077. [More Information]
Vitetta, L. (2022). Can krill oil from small crustaceans be a panacea that alleviates symptoms of knee osteoarthritis? The American Journal of Clinical Nutrition, 116(3), 621-622. [More Information]
Vitetta, L., Sikali, J., Fletcher, C., Henson, J. (2022). Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences. Supportive Care in Cancer, 30(11), 8619-8621. [More Information]
Daniel, K., Vitetta, L., Fiatarone Singh, M. (2022). Effects of olives and their constituents on the expression of ulcerative colitis: A systematic review of randomized controlled trials. British Journal of Nutrition, 127(8), 1153-1171. [More Information]
Chen, J., Vitetta, L. (2022). Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19. Clinical and Translational Gastroenterology, 13(1), E00440. [More Information]
Chen, J., Vitetta, L., Henson, J., Hall, S. (2022). Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis. International Journal of Tryptophan Research, 15. [More Information]
Clarke, S., Butcher, B., McLachlan, A., Henson, J., Rutolo, D., Hall, S., Vitetta, L. (2022). Pilot clinical and pharmacokinetic study of Δ⁹-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain. PloS One, 17(10 October). [More Information]
Vitetta, L., Andersen, T., Quezada, M., Rutolo, D., Henson, J. (2022). Re: "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" by Crippa et al. Cannabis and Cannabinoid Research, 7(2), 231-233. [More Information]
Henson, J., Vitetta, L., Hall, S. (2022). Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions. Inflammopharmacology, 30(4), 1167-1178. [More Information]
Chen, J., Vitetta, L. (2022). The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes. Frontiers in Bioscience - Scholar, 14(3). [More Information]
Vitetta, L. (2022). The vermiform cecal appendix, expendable or essential? A narrative review. Current Opinion in Gastroenterology, 38(6), 570-576. [More Information]
Vitetta, L., Butcher, B., Henson, J., Rutolo, D., Hall, S. (2021). A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study. Inflammopharmacology, 29(5), 1361-1370. [More Information]
Chen, J., Hall, S., Vitetta, L. (2021). Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Reviews in Medical Virology, 31(5), 1-13. [More Information]
Chen, J., Vitetta, L. (2021). Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19. Clinical Immunology, 232, 108870. [More Information]
Vitetta, L., Sikali, J. (2021). Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain. Canadian Journal of Anaesthesia, 68(11), 1707-1708. [More Information]
Henson, J., Vitetta, L., Quezada, M., Hall, S. (2021). Enhancing endocannabinoid control of stress with cannabidiol. Journal of Clinical Medicine, 10(24), 5852. [More Information]
Chen, J., Vitetta, L. (2021). Gut-brain axis in the neurological comorbidity of COVID-19. Brain Communications, 3(2), fcab118. [More Information]
Chen, J., Vitetta, L. (2021). Increased PD-L1 expression may be associated with the cytokine storm and CD8 + T-cell exhaustion in severe COVID-19. The Journal of Infectious Diseases, 223(9), 1659-1660. [More Information]
Chen, J., Vitetta, L. (2021). Intestinal dysbiosis in celiac disease: Decreased butyrate production may facilitate the onset of the disease. Proceedings of the National Academy of Sciences of the United States of America, 118(41), e2113655118. [More Information]
Chen, J., Vitetta, L. (2021). Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19. Journal of Clinical Medicine, 10(13), 2903. [More Information]
Osborne, S., Masci, P., Du, Q., Daniel, R., Desilva, K., Vitetta, L., Zhao, K., Seymour, R. (2021). Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism. Inflammopharmacology, 29(2), 525-535. [More Information]
Chen, J., Vitetta, L. (2021). The gut-liver axis in chronic liver disease associated with severe COVID-19. European Journal of Gastroenterology and Hepatology, 33(1S Suppl 1), e1103. [More Information]
Chen, J., Vitetta, L., Henson, J., Hall, S. (2021). The intestinal microbiota and improving the efficacy of COVID-19 vaccinations. Journal of Functional Foods, 87, 104850. [More Information]
Vitetta, L., Butcher, B., Dal Forno, S., Vitetta, G., Nikov, T., Hall, S., Steels, E. (2020). A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes. Medicines, 7(4), 1-16. [More Information]
Chen, J., Vitetta, L. (2020). Butyrate in IBD therapy. Gastroenterology, 158(5), 1511-1513. [More Information]
Chen, J., Vitetta, L. (2020). Gut microbiota metabolites in nafld pathogenesis and therapeutic implications. International Journal of Molecular Sciences, 21(15), 1-19. [More Information]
Chen, J., Vitetta, L. (2020). Letter to the Editor: Could Butyrate Be Incorporated With Farnesoid X Receptor Agonist Cilofexor to Enhance Primary Sclerosing Cholangitis Treatment? Hepatology, 72(4), 1497-1498. [More Information]
Vitetta, L. (2020). Mind body medicine: a tangible link between the gut and the brain. Annals of Translational Medicine, 8(4), 64. [More Information]
Chen, J., Vitetta, L. (2020). Mitochondria could be a potential key mediator linking the intestinal microbiota to depression. Journal Of Cellular Biochemistry, 121(1), 17-24. [More Information]
Vitetta, L., Henson, J. (2020). Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease. Hepatobiliary Surgery and Nutrition, 9(4), 526-529. [More Information]
Palacios, T., Vitetta, L., Coulson, S., Madigan, C., Lam, Y., Manuel, R., Briskey, D., Hendy, C., Kim, J., Ishoey, T., Caterson, I., et al (2020). Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study. Nutrients, 12(7), 1-15. [More Information]
Chen, J., Sali, A., Vitetta, L. (2020). The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms. Future Microbiology, 15, 541-555. [More Information]
Chen, J., Vitetta, L. (2020). The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation. Immune Network, 20(2), 1-18. [More Information]
Steels, E., Venkatesh, R., Steels, E., Vitetta, G., Vitetta, L. (2019). A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacology, 27(3), 475-485. [More Information]
Chen, J., Vitetta, L. (2019). Activation of T-regulatory cells by a synbiotic may be important for its anti-inflammatory effect. European Journal of Nutrition, 58(8), 3379-3380. [More Information]
Chen, J., Vitetta, L. (2019). Bile acids and butyrate in the effects of probiotics/synbiotics on nonalcoholic fatty liver disease. European Journal of Gastroenterology and Hepatology, 31(11), 1475-1476. [More Information]
Chen, J., Vitetta, L. (2019). Comments on "Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial". International Journal of Colorectal Disease, 34(8), 1503-1504. [More Information]
Chen, J., Zhao, K., Vitetta, L. (2019). Effects of Intestinal Microbial-Elaborated Butyrate on Oncogenic Signaling Pathways. Nutrients, 11(5), 1-26. [More Information]
Vitetta, L., Llewellyn, H., Oldfield, D. (2019). Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia. Microorganisms, 7(8), 1-12. [More Information]
Chen, J., Thomsen, M., Vitetta, L. (2019). Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. Journal Of Cellular Biochemistry, 120(3), 2713-2720. [More Information]
Vitetta, L. (2019). Probiotics Can Break the Toxic Relationship Between the Intestinal Microbiome and the Kidney. Digestive Diseases and Sciences, 64(2), 297-299. [More Information]
Chen, J., Vitetta, L. (2019). Signalling molecules and epigenetic targeting in cancer immunotherapy - Comments on "Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma". Cellular Immunology, 346, 10397. [More Information]
Vitetta, L., Chen, J., Clarke, S. (2019). The vermiform appendix: an immunological organ sustaining a microbiome inoculum. Clinical Science, 133(1), 1-8. [More Information]
Thomsen, M., Vitetta, L. (2019). Zinc deficits, mucositis, and mucosal macrophage perturbation: is there a relationship? Current Opinion In Clinical Nutrition And Metabolic Care, 22(5), 365-370. [More Information]
Thomsen, M., Vitetta, L. (2018). Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis. Integrative Cancer Therapies, 17(4), 1027-1047. [More Information]
Vitetta, L., Saltzman, E., Thomsen, M., Nikov, T., Hall, S. (2018). Correction: Vitetta, L; et al Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes Vaccines 2017, 5, 50. Vaccines, 6(2), 26. [More Information]
Vitetta, L., Vitetta, G., Hall, S. (2018). Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages. Frontiers in Immunology, 9, 1-15. [More Information]
Ellis, R., Small, D., Ng, K., Vesey, D., Vitetta, L., Francis, R., Gobe, G., Morais, C. (2018). Indoxyl Sulfate Induces Apoptosis and Hypertrophy in Human Kidney Proximal Tubular Cells. Toxicologic Pathology, 46(4), 449-459. [More Information]
Chen, J., Vitetta, L. (2018). Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber. Clinical Colorectal Cancer, 17(3), e541-e544. [More Information]
Saltzman, E., Palacios, T., Thomsen, M., Vitetta, L. (2018). Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease. Frontiers in Microbiology, 9, 1-11. [More Information]
Vitetta, L., Zhou, J., Manuel, R., Dal Forno, S., Hall, S., Rutolo, D. (2018). Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum. Journal of Functional Biomaterials, 9(1), 1-9. [More Information]
Vitetta, L., Vitetta, G., Hall, S. (2018). The Brain-Intestinal Mucosa-Appendix- Microbiome-Brain Loop. Diseases, 6(2), 1-9. [More Information]
Vitetta, L., Leong, A., Zhou, J., Dal Forno, S., Hall, S., Rutolo, D. (2018). The Plasma Bioavailability of Coenzyme Q10 Absorbed from the Gut and the Oral Mucosa. Journal of Functional Biomaterials, 9(4), 1-8. [More Information]
Thomsen, M., Clarke, S., Vitetta, L. (2018). The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments. Beneficial Microbes, 9(6), 899-916. [More Information]
Liu, X., Hollingworth, S., Williams, G., Martin, J., Kostner, K., Crompton, D., Xue, C., Vitetta, L. (2018). Use of complementary and alternative medicines in people with depresssion and central obesity: findings from a Tai Chi and Qigong study. Journal of Traditional Chinese Medical Sciences, 5, 100-109. [More Information]
Bambling, M., Edwards, S., Hall, S., Vitetta, L. (2017). A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested. Inflammopharmacology, 25(2), 271-274. [More Information]
Schloss, J., Colosimo, M., Airey, C., Masci, P., Linnane, A., Vitetta, L. (2017). A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Supportive Care in Cancer, 25(1), 195-204. [More Information]
Vitetta, L., Saltzman, E., Thomsen, M., Nikov, T., Hall, S. (2017). Adjuvant probiotics and the intestinal microbiome: Enhancing vaccines and immunotherapy outcomes. Vaccines, 5(4), 1-17. [More Information]
Detering, M., Steels, E., Koyyalamudi, S., Allifranchini, E., Bocchietto, E., Vitetta, L. (2017). Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study. BioFactors, 43(6), 789-800. [More Information]
Heritage, M., Jaskowski, L., Bridle, K., Campbell, C., Briskey, D., Britton, L., Fletcher, L., Vitetta, L., Subramaniam, V., Crawford, D. (2017). Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe(-/-) mice. World Journal of Gastrointestinal Pathophysiology, 8(2), 67-76. [More Information]
Marx, W., Ried, K., McCarthy, A., Vitetta, L., Sali, A., McKavanagh, D., Isenring, L. (2017). Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review. Critical Reviews in Food Science and Nutrition, 57(1), 141-146. [More Information]
Schloss, J., Colosimo, M., Vitetta, L. (2017). Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review. Critical Reviews in Food Science and Nutrition, 57(6), 1107-1118. [More Information]
Saltzman, E., Thomsen, M., Hall, S., Vitetta, L. (2017). Perna canaliculus and the intestinal microbiome. Marine Drugs, 15(7), 1-13. [More Information]
Vitetta, L., Coulson, S., Thomsen, M., Nguyen, T., Hall, S. (2017). Probiotics, D–Lactic acidosis, oxidative stress and strain specificity. Gut Microbes, 8(4), 311-322. [More Information]
Palacios, T., Vitetta, L., Coulson, S., Madigan, C., Denyer, G., Caterson, I. (2017). The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial. Trials, 18(1), 1-8. [More Information]
Marx, W., McCarthy, A., Ried, K., McKavanagh, D., Vitetta, L., Sali, A., Lohning, A., Isenring, E. (2017). The effect of a standardized ginger extract on chemotherapy-induced nausea-related quality of life in patients undergoing moderately or highly emetogenic chemotherapy: A double blind, randomized, placebo controlled trial. Nutrients, 9(8), 1-13. [More Information]
Liu, X., Furuya-Kanamori, L., Siskind, D., Crompton, D., Williams, G., Kostner, K., Vitetta, L., Doi, S. (2016). An evidence-based scale for the antecedents of depressive symptoms in Australian adults. Australasian Psychiatry, 24(5), 466-469. [More Information]
Ellis, R., Small, D., Vesey, D., Johnson, D., Francis, R., Vitetta, L., Gobe, G., Morais, C. (2016). Indoxyl sulphate and kidney disease: causes, consequences and interventions. Nephrology, 21(3), 170-177. [More Information]
Vitetta, L. (2016). Lactobacillus acidophilus Restores Functionality in Uremic Macrophages: Plausible or Lacking Evidence? Digestive Diseases and Sciences, 61(6), 1417-1419. [More Information]
Vitetta, L., Saltzman, E., Nikov, T., Ibrahim, I., Hall, S. (2016). Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites. Journal of Clinical Medicine, 5(11), 1-11. [More Information]
Schloss, J., Colosimo, M., Vitetta, L. (2016). New Insights into potential prevention and management options for chemotherapy-induced peripheral neuropathy. Asia-Pacific Journal of Oncology Nursing, 3(1), 73-85. [More Information]
Briskey, D., Heritage, M., Jaskowski, L., Peake, J., Gobe, G., Subramaniam, N., Crawford, D., Campbell, C., Vitetta, L. (2016). Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology, 9(4), 463-472. [More Information]
Rao, A., Steels, E., Inder, W., Abraham, S., Vitetta, L. (2016). Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study. The Aging Male, 19(2), 134-142. [More Information]
Schloss, J., Colosimo, M., Airey, C., Vitetta, L. (2015). Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. Supportive Care in Cancer, 23(7), 1843-1850. [More Information]
Rao, A., Steels, E., Beccaria, G., Inder, W., Vitetta, L. (2015). Influence of a Specialized Trigonella foenum-graecum Seed Extract (Libifem), on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study. Phytotherapy Research, 29(8), 1123-1130. [More Information]
Morias, C., Vitetta, L. (2015). Journal of Controversies in Biomedical Research - the Need of the Hour. Journal of Controversies in Biomedical Research, 1(1), 1-3. [More Information]
Vitetta, L., Hall, S., Coulson, S. (2015). Metabolic Interactions in the Gastrointestinal Tract (GIT):Host, Commensal, Probiotics, and Bacteriophage Influences. Microorganisms, 3, 913-932. [More Information]
Vitetta, L., Coulson, S., Linnane, A. (2015). Reactive Oxygen Species in Disease: Rebuttal of a Conventional Concept. Journal of Controversies in Biomedical Research, 1(1), 23-27. [More Information]
Bambling, M., Parham, S., Coulson, S., Vitetta, L. (2015). S-adenosylmethionine (SAMe) and Magnesium Orotate as adjunctives to SSRIs in sub-optimal treatment response of depression in adults: A pilot study. Advances in Integrative Medicine, 2(1), 56-62. [More Information]
Chen, C., Zhao, K., Masci, P., Lakhani, S., Antonsson, A., Simpson, P., Vitetta, L. (2015). TGFÎ² isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications. BMC Cancer, 15(1), 1-12. [More Information]
Vitetta, L., Linnane, A. (2014). Endocellular regulation by free radicals and hydrogen peroxide: key determinants of the inflammatory response. Inflammopharmacology, 22(2), 69-72. [More Information]
Vitetta, L., Hall, S., Linnane, A. (2014). Live probiotic cultures and the gastrointestinal tract: symbiotic preservation of tolerance whilst attenuating pathogenicity. Frontiers in Cellular and Infection Microbiology, 4, 1-5. [More Information]
Vitetta, L., Briskey, D., Alford, H., Hall, S., Coulson, S. (2014). Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology, 22(3), 135-154. [More Information]
Vitetta, L., Bambling, M., Alford, H. (2014). The gastrointestinal tract microbiome, probiotics, and mood. Inflammopharmacology, 22(6), 333-339. [More Information]
Vitetta, L., Manuel, R., Zhou, J., Linnane, A., Hall, S., Coulson, S. (2014). The Overarching Influence of the Gut Microbiome on End-Organ Function: The Role of Live Probiotic Cultures. Pharmaceuticals, 7(9), 954-989. [More Information]

show 91 more

By Year

Expand all

2024

Thomsen, M., Vemuri, R., Huygens, F., Clarke, S., Vitetta, L. (2024). An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid. Inflammopharmacology. [More Information]
Vitetta, L., Henson, J. (2024). Comment on “Hall et al., Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain”. Journal of Cannabis Research, 6(1), 13. [More Information]
Vitetta, L., Oldfield, D., Sali, A. (2024). Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods. Frontiers in Bioscience, 16(2). [More Information]
Strodl, E., Bambling, M., Parnam, S., Ritchie, G., Cramb, S., Vitetta, L. (2024). Probiotics and magnesium orotate for the treatment of major depressive disorder: a randomised double blind controlled trial. Scientific Reports, 14(1), 20841. [More Information]

show 1 more

2023

Ritchie, G., Strodl, E., Parham, S., Bambling, M., Cramb, S., Vitetta, L. (2023). An exploratory study of the gut microbiota in major depression with anxious distress. Journal of Affective Disorders, 320, 595-604. [More Information]
Chen, J., Vitetta, L. (2023). Is miR-223 Upregulation in Inflammatory Bowel Diseases a Protective Response? Frontiers in Bioscience, 15(1). [More Information]
Vitetta, L. (2023). Letter on “Role of gut microbiome in immune regulation and immune checkpoint therapy of colorectal cancer”. Medical Oncology: a leading journal in clinical oncology, 40(5), 143. [More Information]
Vitetta, L., Gorgani, N., Vitetta, G., Henson, J. (2023). Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus. Biomolecules, 13(9), 1307. [More Information]
Vitetta, L., Bambling, M., Strodl, E. (2023). Probiotics and Commensal Bacteria Metabolites Trigger Epigenetic Changes in the Gut and Influence Beneficial Mood Dispositions. Microorganisms, 11(5). [More Information]

show 2 more

2022

Pickering, E., Steels, E., Steadman, K., Rao, A., Vitetta, L. (2022). A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain. Inflammopharmacology, 30(6), 2063-2077. [More Information]
Vitetta, L. (2022). Can krill oil from small crustaceans be a panacea that alleviates symptoms of knee osteoarthritis? The American Journal of Clinical Nutrition, 116(3), 621-622. [More Information]
Vitetta, L., Sikali, J., Fletcher, C., Henson, J. (2022). Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences. Supportive Care in Cancer, 30(11), 8619-8621. [More Information]
Daniel, K., Vitetta, L., Fiatarone Singh, M. (2022). Effects of olives and their constituents on the expression of ulcerative colitis: A systematic review of randomized controlled trials. British Journal of Nutrition, 127(8), 1153-1171. [More Information]
Chen, J., Vitetta, L. (2022). Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19. Clinical and Translational Gastroenterology, 13(1), E00440. [More Information]
Chen, J., Vitetta, L., Henson, J., Hall, S. (2022). Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis. International Journal of Tryptophan Research, 15. [More Information]
Clarke, S., Butcher, B., McLachlan, A., Henson, J., Rutolo, D., Hall, S., Vitetta, L. (2022). Pilot clinical and pharmacokinetic study of Δ⁹-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain. PloS One, 17(10 October). [More Information]
Vitetta, L., Andersen, T., Quezada, M., Rutolo, D., Henson, J. (2022). Re: "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" by Crippa et al. Cannabis and Cannabinoid Research, 7(2), 231-233. [More Information]
Henson, J., Vitetta, L., Hall, S. (2022). Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions. Inflammopharmacology, 30(4), 1167-1178. [More Information]
Chen, J., Vitetta, L. (2022). The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes. Frontiers in Bioscience - Scholar, 14(3). [More Information]
Vitetta, L. (2022). The vermiform cecal appendix, expendable or essential? A narrative review. Current Opinion in Gastroenterology, 38(6), 570-576. [More Information]

show 8 more

2021

Vitetta, L., Butcher, B., Henson, J., Rutolo, D., Hall, S. (2021). A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study. Inflammopharmacology, 29(5), 1361-1370. [More Information]
Chen, J., Hall, S., Vitetta, L. (2021). Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Reviews in Medical Virology, 31(5), 1-13. [More Information]
Chen, J., Vitetta, L. (2021). Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19. Clinical Immunology, 232, 108870. [More Information]
Vitetta, L., Sikali, J. (2021). Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain. Canadian Journal of Anaesthesia, 68(11), 1707-1708. [More Information]
Henson, J., Vitetta, L., Quezada, M., Hall, S. (2021). Enhancing endocannabinoid control of stress with cannabidiol. Journal of Clinical Medicine, 10(24), 5852. [More Information]
Chen, J., Vitetta, L. (2021). Gut-brain axis in the neurological comorbidity of COVID-19. Brain Communications, 3(2), fcab118. [More Information]
Chen, J., Vitetta, L. (2021). Increased PD-L1 expression may be associated with the cytokine storm and CD8 + T-cell exhaustion in severe COVID-19. The Journal of Infectious Diseases, 223(9), 1659-1660. [More Information]
Chen, J., Vitetta, L. (2021). Intestinal dysbiosis in celiac disease: Decreased butyrate production may facilitate the onset of the disease. Proceedings of the National Academy of Sciences of the United States of America, 118(41), e2113655118. [More Information]
Chen, J., Vitetta, L. (2021). Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19. Journal of Clinical Medicine, 10(13), 2903. [More Information]
Osborne, S., Masci, P., Du, Q., Daniel, R., Desilva, K., Vitetta, L., Zhao, K., Seymour, R. (2021). Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism. Inflammopharmacology, 29(2), 525-535. [More Information]
Chen, J., Vitetta, L. (2021). The gut-liver axis in chronic liver disease associated with severe COVID-19. European Journal of Gastroenterology and Hepatology, 33(1S Suppl 1), e1103. [More Information]
Chen, J., Vitetta, L., Henson, J., Hall, S. (2021). The intestinal microbiota and improving the efficacy of COVID-19 vaccinations. Journal of Functional Foods, 87, 104850. [More Information]

show 9 more

2020

Vitetta, L., Butcher, B., Dal Forno, S., Vitetta, G., Nikov, T., Hall, S., Steels, E. (2020). A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes. Medicines, 7(4), 1-16. [More Information]
Chen, J., Vitetta, L. (2020). Butyrate in IBD therapy. Gastroenterology, 158(5), 1511-1513. [More Information]
Chen, J., Vitetta, L. (2020). Gut microbiota metabolites in nafld pathogenesis and therapeutic implications. International Journal of Molecular Sciences, 21(15), 1-19. [More Information]
Chen, J., Vitetta, L. (2020). Letter to the Editor: Could Butyrate Be Incorporated With Farnesoid X Receptor Agonist Cilofexor to Enhance Primary Sclerosing Cholangitis Treatment? Hepatology, 72(4), 1497-1498. [More Information]
Vitetta, L. (2020). Mind body medicine: a tangible link between the gut and the brain. Annals of Translational Medicine, 8(4), 64. [More Information]
Chen, J., Vitetta, L. (2020). Mitochondria could be a potential key mediator linking the intestinal microbiota to depression. Journal Of Cellular Biochemistry, 121(1), 17-24. [More Information]
Vitetta, L., Henson, J. (2020). Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease. Hepatobiliary Surgery and Nutrition, 9(4), 526-529. [More Information]
Palacios, T., Vitetta, L., Coulson, S., Madigan, C., Lam, Y., Manuel, R., Briskey, D., Hendy, C., Kim, J., Ishoey, T., Caterson, I., et al (2020). Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study. Nutrients, 12(7), 1-15. [More Information]
Chen, J., Sali, A., Vitetta, L. (2020). The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms. Future Microbiology, 15, 541-555. [More Information]
Chen, J., Vitetta, L. (2020). The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation. Immune Network, 20(2), 1-18. [More Information]

show 7 more

2019

Steels, E., Venkatesh, R., Steels, E., Vitetta, G., Vitetta, L. (2019). A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacology, 27(3), 475-485. [More Information]
Chen, J., Vitetta, L. (2019). Activation of T-regulatory cells by a synbiotic may be important for its anti-inflammatory effect. European Journal of Nutrition, 58(8), 3379-3380. [More Information]
Chen, J., Vitetta, L. (2019). Bile acids and butyrate in the effects of probiotics/synbiotics on nonalcoholic fatty liver disease. European Journal of Gastroenterology and Hepatology, 31(11), 1475-1476. [More Information]
Chen, J., Vitetta, L. (2019). Comments on "Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial". International Journal of Colorectal Disease, 34(8), 1503-1504. [More Information]
Chen, J., Zhao, K., Vitetta, L. (2019). Effects of Intestinal Microbial-Elaborated Butyrate on Oncogenic Signaling Pathways. Nutrients, 11(5), 1-26. [More Information]
Vitetta, L., Llewellyn, H., Oldfield, D. (2019). Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia. Microorganisms, 7(8), 1-12. [More Information]
Chen, J., Thomsen, M., Vitetta, L. (2019). Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. Journal Of Cellular Biochemistry, 120(3), 2713-2720. [More Information]
Vitetta, L. (2019). Probiotics Can Break the Toxic Relationship Between the Intestinal Microbiome and the Kidney. Digestive Diseases and Sciences, 64(2), 297-299. [More Information]
Chen, J., Vitetta, L. (2019). Signalling molecules and epigenetic targeting in cancer immunotherapy - Comments on "Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma". Cellular Immunology, 346, 10397. [More Information]
Vitetta, L., Chen, J., Clarke, S. (2019). The vermiform appendix: an immunological organ sustaining a microbiome inoculum. Clinical Science, 133(1), 1-8. [More Information]
Thomsen, M., Vitetta, L. (2019). Zinc deficits, mucositis, and mucosal macrophage perturbation: is there a relationship? Current Opinion In Clinical Nutrition And Metabolic Care, 22(5), 365-370. [More Information]

show 8 more

2018

Thomsen, M., Vitetta, L. (2018). Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis. Integrative Cancer Therapies, 17(4), 1027-1047. [More Information]
Vitetta, L., Saltzman, E., Thomsen, M., Nikov, T., Hall, S. (2018). Correction: Vitetta, L; et al Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes Vaccines 2017, 5, 50. Vaccines, 6(2), 26. [More Information]
Vitetta, L., Vitetta, G., Hall, S. (2018). Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages. Frontiers in Immunology, 9, 1-15. [More Information]
Ellis, R., Small, D., Ng, K., Vesey, D., Vitetta, L., Francis, R., Gobe, G., Morais, C. (2018). Indoxyl Sulfate Induces Apoptosis and Hypertrophy in Human Kidney Proximal Tubular Cells. Toxicologic Pathology, 46(4), 449-459. [More Information]
Chen, J., Vitetta, L. (2018). Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber. Clinical Colorectal Cancer, 17(3), e541-e544. [More Information]
Saltzman, E., Palacios, T., Thomsen, M., Vitetta, L. (2018). Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease. Frontiers in Microbiology, 9, 1-11. [More Information]
Vitetta, L., Zhou, J., Manuel, R., Dal Forno, S., Hall, S., Rutolo, D. (2018). Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum. Journal of Functional Biomaterials, 9(1), 1-9. [More Information]
Vitetta, L., Vitetta, G., Hall, S. (2018). The Brain-Intestinal Mucosa-Appendix- Microbiome-Brain Loop. Diseases, 6(2), 1-9. [More Information]
Vitetta, L., Leong, A., Zhou, J., Dal Forno, S., Hall, S., Rutolo, D. (2018). The Plasma Bioavailability of Coenzyme Q10 Absorbed from the Gut and the Oral Mucosa. Journal of Functional Biomaterials, 9(4), 1-8. [More Information]
Thomsen, M., Clarke, S., Vitetta, L. (2018). The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments. Beneficial Microbes, 9(6), 899-916. [More Information]
Liu, X., Hollingworth, S., Williams, G., Martin, J., Kostner, K., Crompton, D., Xue, C., Vitetta, L. (2018). Use of complementary and alternative medicines in people with depresssion and central obesity: findings from a Tai Chi and Qigong study. Journal of Traditional Chinese Medical Sciences, 5, 100-109. [More Information]

show 8 more

2017

Bambling, M., Edwards, S., Hall, S., Vitetta, L. (2017). A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested. Inflammopharmacology, 25(2), 271-274. [More Information]
Schloss, J., Colosimo, M., Airey, C., Masci, P., Linnane, A., Vitetta, L. (2017). A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Supportive Care in Cancer, 25(1), 195-204. [More Information]
Vitetta, L., Saltzman, E., Thomsen, M., Nikov, T., Hall, S. (2017). Adjuvant probiotics and the intestinal microbiome: Enhancing vaccines and immunotherapy outcomes. Vaccines, 5(4), 1-17. [More Information]
Detering, M., Steels, E., Koyyalamudi, S., Allifranchini, E., Bocchietto, E., Vitetta, L. (2017). Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study. BioFactors, 43(6), 789-800. [More Information]
Heritage, M., Jaskowski, L., Bridle, K., Campbell, C., Briskey, D., Britton, L., Fletcher, L., Vitetta, L., Subramaniam, V., Crawford, D. (2017). Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe(-/-) mice. World Journal of Gastrointestinal Pathophysiology, 8(2), 67-76. [More Information]
Marx, W., Ried, K., McCarthy, A., Vitetta, L., Sali, A., McKavanagh, D., Isenring, L. (2017). Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review. Critical Reviews in Food Science and Nutrition, 57(1), 141-146. [More Information]
Schloss, J., Colosimo, M., Vitetta, L. (2017). Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review. Critical Reviews in Food Science and Nutrition, 57(6), 1107-1118. [More Information]
Saltzman, E., Thomsen, M., Hall, S., Vitetta, L. (2017). Perna canaliculus and the intestinal microbiome. Marine Drugs, 15(7), 1-13. [More Information]
Vitetta, L., Coulson, S., Thomsen, M., Nguyen, T., Hall, S. (2017). Probiotics, D–Lactic acidosis, oxidative stress and strain specificity. Gut Microbes, 8(4), 311-322. [More Information]
Palacios, T., Vitetta, L., Coulson, S., Madigan, C., Denyer, G., Caterson, I. (2017). The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial. Trials, 18(1), 1-8. [More Information]
Marx, W., McCarthy, A., Ried, K., McKavanagh, D., Vitetta, L., Sali, A., Lohning, A., Isenring, E. (2017). The effect of a standardized ginger extract on chemotherapy-induced nausea-related quality of life in patients undergoing moderately or highly emetogenic chemotherapy: A double blind, randomized, placebo controlled trial. Nutrients, 9(8), 1-13. [More Information]

show 8 more

2016

Liu, X., Furuya-Kanamori, L., Siskind, D., Crompton, D., Williams, G., Kostner, K., Vitetta, L., Doi, S. (2016). An evidence-based scale for the antecedents of depressive symptoms in Australian adults. Australasian Psychiatry, 24(5), 466-469. [More Information]
Ellis, R., Small, D., Vesey, D., Johnson, D., Francis, R., Vitetta, L., Gobe, G., Morais, C. (2016). Indoxyl sulphate and kidney disease: causes, consequences and interventions. Nephrology, 21(3), 170-177. [More Information]
Vitetta, L. (2016). Lactobacillus acidophilus Restores Functionality in Uremic Macrophages: Plausible or Lacking Evidence? Digestive Diseases and Sciences, 61(6), 1417-1419. [More Information]
Vitetta, L., Saltzman, E., Nikov, T., Ibrahim, I., Hall, S. (2016). Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites. Journal of Clinical Medicine, 5(11), 1-11. [More Information]
Schloss, J., Colosimo, M., Vitetta, L. (2016). New Insights into potential prevention and management options for chemotherapy-induced peripheral neuropathy. Asia-Pacific Journal of Oncology Nursing, 3(1), 73-85. [More Information]
Briskey, D., Heritage, M., Jaskowski, L., Peake, J., Gobe, G., Subramaniam, N., Crawford, D., Campbell, C., Vitetta, L. (2016). Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology, 9(4), 463-472. [More Information]
Rao, A., Steels, E., Inder, W., Abraham, S., Vitetta, L. (2016). Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study. The Aging Male, 19(2), 134-142. [More Information]

show 4 more

2015

Schloss, J., Colosimo, M., Airey, C., Vitetta, L. (2015). Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. Supportive Care in Cancer, 23(7), 1843-1850. [More Information]
Vitetta, L., Palacios, T., Hall, S., Coulson, S. (2015). Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End-Organ Physiology. In K D Rainsford, M C Powanda, M W Whitehouse (Eds.), Novel Natural Products:Therapeutic Effects in Pain, Arthritis and Gastro-intestinal Diseases, (pp. 1-33). Basel: Springer. [More Information]
Rao, A., Steels, E., Beccaria, G., Inder, W., Vitetta, L. (2015). Influence of a Specialized Trigonella foenum-graecum Seed Extract (Libifem), on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study. Phytotherapy Research, 29(8), 1123-1130. [More Information]
Morias, C., Vitetta, L. (2015). Journal of Controversies in Biomedical Research - the Need of the Hour. Journal of Controversies in Biomedical Research, 1(1), 1-3. [More Information]
Vitetta, L., Hall, S., Coulson, S. (2015). Metabolic Interactions in the Gastrointestinal Tract (GIT):Host, Commensal, Probiotics, and Bacteriophage Influences. Microorganisms, 3, 913-932. [More Information]
Coulson, S., Palacios, T., Vitetta, L. (2015). Perna canaliculus (Green-Lipped Mussel): Bioactive Components and Therapeutic Evaluation for Chronic Health Conditions. In K D Rainsford, M C Powanda, M W Whitehouse (Eds.), Novel Natural Products:Therapeutic Effects in Pain, Arthritis and Gastro-intestinal Diseases, (pp. 91-132). Basel: Springer. [More Information]
Vitetta, L., Coulson, S., Linnane, A. (2015). Reactive Oxygen Species in Disease: Rebuttal of a Conventional Concept. Journal of Controversies in Biomedical Research, 1(1), 23-27. [More Information]
Bambling, M., Parham, S., Coulson, S., Vitetta, L. (2015). S-adenosylmethionine (SAMe) and Magnesium Orotate as adjunctives to SSRIs in sub-optimal treatment response of depression in adults: A pilot study. Advances in Integrative Medicine, 2(1), 56-62. [More Information]
Chen, C., Zhao, K., Masci, P., Lakhani, S., Antonsson, A., Simpson, P., Vitetta, L. (2015). TGFÎ² isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications. BMC Cancer, 15(1), 1-12. [More Information]

show 6 more

2014

Vitetta, L., Linnane, A. (2014). Endocellular regulation by free radicals and hydrogen peroxide: key determinants of the inflammatory response. Inflammopharmacology, 22(2), 69-72. [More Information]
Vitetta, L., Hall, S., Linnane, A. (2014). Live probiotic cultures and the gastrointestinal tract: symbiotic preservation of tolerance whilst attenuating pathogenicity. Frontiers in Cellular and Infection Microbiology, 4, 1-5. [More Information]
Vitetta, L., Briskey, D., Alford, H., Hall, S., Coulson, S. (2014). Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology, 22(3), 135-154. [More Information]
Vitetta, L., Bambling, M., Alford, H. (2014). The gastrointestinal tract microbiome, probiotics, and mood. Inflammopharmacology, 22(6), 333-339. [More Information]
Vitetta, L., Manuel, R., Zhou, J., Linnane, A., Hall, S., Coulson, S. (2014). The Overarching Influence of the Gut Microbiome on End-Organ Function: The Role of Live Probiotic Cultures. Pharmaceuticals, 7(9), 954-989. [More Information]

show 2 more

Selected Grants

2018

Sense-and-Dispense - breaking barriers in cancer pain treatment using iontophoretic tattoo-like cannabinoids delivery systems., Chrzanowski W, Zhao N, Divakarla S, Vitetta L, Liu J, Chen S, Hall S, Office of Global Engagement/Partnership Collaboration Awards

Conferences

Alex Seungyeon Byun, Luis Vitetta, Hak-Kim Chan and Philip Chi Lip Kwok.Nebulisation of Lactobacillus rhamnosus GG with vibrating mesh and jet nebulisers. Asian Federation for Pharmaceutical Sciences 2023 | Nov 8-10, 2023, Hanoi Vietnam.

Henson JD, Vitetta L, Fletcher C, Lu C, Quezada, M Moroni I, Andersen T, Hall S. Can oral administration provide a suitable plasma cannabinoid profile for the effective treatment of chronic pain? IASP World Congress on Pain. Toronto, Canada. 2022.

Clarke S, Butcher BE, McLachlan AJ, Hendon JD, Rutolo D, Hall S,Vitetta L. Can oral administration provide a suitable plasma cannabinoid profile for the effective treatment of chronic pain? IASP World Congress on Pain 19-23 September 2022, TorontoCanada.

Sikali JF, Fletcher C, Gillespie A, Hall L, Henson JD, Hall S, Vitetta L, and the Medical Science Liaison Team at Medlab Clinical. An Observational Study Investigating And Auditing The Safety, Tolerability And Further Efficacy Characteristics Of A Pharmaceutical Grade Cannabis-Based Medicine Prescribed To Eligible Patients For The Management Of Cancer Related Or Non-Cancer Related Pain In General And Specialty Medical Practices Australia-Wide. 48^th Annual Scientific Meeting COSA 16-18^th November, Brisbane 2021.

Chen J,Vitetta L. Butyrate Sensitizes Epithelioid Mesothelioma Cells to Oxaliplatin. 15th Meeting of the International Mesothelioma Interest Group-Virtual. Poster. In section: Mesothelioma Biology and Novel Targets | 306 (iMig 2021) May 7–9, 2021.

Clarke S, Butcher B, McLachlan AJ, Henson JD, Rutolo D, Hall S,VitettaL.Can improved mucosal absorption allow a THC/CBD oro-buccal spray to achieve clinical efficacy in chronic pain? ANZCA ASM Poster (Anaesthesia and Pain Medicine in Australia and NewZealand) 30^th Apr-4^th May Melbourne 2021.

Vitetta L,Henson HD,Rutolo R, Hall S.An oro-buccal nanoparticle-cannabis delivered medicine for pain management in cancer. 9th Global Nanotechnology Congress and Expo. Miami, Florida, USA. 13-14 Apr 2020.

Vitetta L, ClarkeS, McLachlanAJ, Henson J, Fletcher C, Vitetta G, Rutolo D, Hall S. A Novel Delivery Mechanism for Cannabinoids in Pain Management. Clinical Oncological Society of Australia Scientific Conference, Adelaide, 12-14 Nov 2019.

Thomsen M, Vitetta L, Clarke S. Intestinal microbiome and chemotherapy-induced neutropenia. Clinical Oncological Society of Australia Scientific Conference, Adelaide, 12-14 Nov 2019.

Vitetta L.Mood Disorders and the Brain–Intestinal Mucosa–Appendix–Microbiome–Brain Loop. Keynote Invitation. Probiota Asia Conference, Singapore, 22-24 Oct 2019.

Palacios T, Vitetta L,Caterson I, Kim JN,Soto-Giron M, Ishoey T, Toledo T, Soto J, Schott EM, Briskey D, Madigan C, Coulson S, Lam Y, Hall S. A randomised controlled pilot study to investigate the effect of a multi-species probiotic formulation and metformin as modulators of the intestinal microbiome for the management of diabetes. Nutrients 2019–In Nutritional Advances in the Prevention and Management of Chronic Disease, Sept 25-27; Barcelona, Spain.

Vitetta L, Clarke S, Thomsen M. The intestinal microbiome, chemotherapy and adjuvant treatments with probiotics. Asia-Pacific Journal of Clinical Oncology [Clinical Oncological Society of Australia] 2017; Nov 13-15; 13(4):98, ABS#105. Sydney, Australia.

Palacios T, Vitetta L, Madigan C, Caterson I. Prediabetes and Early Diagnosed T2DM: safety tolerability and pilot exploratory study preliminary results. 5th MICROBIOME R And D And BUSINESS COLLABORATION FORUM: USA COLLABORATIONS IN MICROBIOME RESEARCH, LIVE BACTERIAL THERAPEUTICS, HUMAN HEALTH & DISEASE | 2nd PROBIOTICS CONGRESS: USA. 2-3 Nov 2017. San Diego, USA.

Vitetta L. Cancer Treatments, the Intestinal Microbiome and Probiotics. IPA World Congress | Asia Probiota. 11-13 Oct 2017. Singapore.

Palacios T, Vitetta L, Madigan C, Caterson I . The development of a evidence-based probiotic formulation and its efficacy in obesity and type 2 diabetes. 4th Beneficial Microbes Conference, 9-11 Oct 2017. Amsterdam, The Netherlands.

Kalma B, Ellis RJ, Vitetta L, Wood ST, Gobe GC. Pilot Study: Urinary Indoxyl Sulphate As A Predictor Of Postoperative Kidney Function Following Radical Tumour Nephrectomy. 54^th Australian and New Zealand Society of Nephrology. Annual Scientific Meeting 8-12 Sep 2017. Sydney, Australia.

Vitetta L. The intestinal microbiome, metabolic diseases and probiotics. BIT 15th International Conference: IDDST Jul 26-28 2017. Osaka, Japan.

Palacios T, Caterson I, Madigan C, Vitetta L. The Efficacy of a Novel Probiotic on Glucose Metabolism: A Randomised Controlled Trial. The 4th Latin American Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension. 16-18 Mar 2017. Buenos Aires, Argentina.

Chen T, Ellis R, Morais C, Gobe G, Vitetta L. Nephrotoxic effects of cis-diamminedichloroplatinium II (cisplatin) can be ameliorated using Coenzyme Q10 (CoQ10), 7th World Congress on Targeting Mitochondria. Oct 24–26, 2016. Berlin, Germany.

Palacios T, Vitetta L, Coulson S, Butt H, Caterson I. The Effect of a Multi-Strain Probiotic on Metabolic Bio-Markers in Adults with Prediabetes and Recently Diagnosed Type 2 Diabetes Mellitus (T2DM). ICO May 1-4, 2016, Vancouver, Canada.

Vitetta L. Reactive oxygen species and their lifelong regulation of the metabolome. 6th World Congress on Targeting Mitochondria. Oct 28–30, 2015. Berlin, Germany.

RJ Ellis, DM Small, KL Ng, DA Vesey, L Vitetta, R Francis, C Morais, GC Gobe. Indoxyl Sulphate Induces Hypertrophy and Impaired Metabolic Activity In Cultured Human Proximal Tubular Cells. Aust New Zealand Soc of Nephrol (Annual Scientific Meeting) 2015; Sep 7–9. Canberra, Australia.

Briskey D, Peake J, Coulson S, Vitetta L. High Fat Diet, Probiotics and Non–Alcoholic Fatty Liver Disease 4^th Beneficial Microbes Conference, The Hague, Netherlands, 2015, 75, P25.

Rao A, Steels E, Vitetta L, Inder W, Beccaria G. Influence of a specialized Trigonella foenum-graecum seed extract (Libifem), on testosterone, estradiol and sexual function, a randomized placebo-controlled study. 25th Annual Meeting of The North American Menopause Society October 15–October 18, 2014, Washington, DC. In: Menopause 21(12):1360-1361.

Rao A, Steels E, Vitetta L, Inder W, Beccaria G. Influence of a specialized Trigonella foenum-graecum seed extract (Libifem), on testosterone, estradiol and sexual function, a randomized placebo-controlled study. 25th Annual Meeting of The North American Menopause Society October 15–October 18, 2014, Washington, DC. In: Menopause 21(12):1360-1361.

Marx W, Ried K, Mckavanagh D, Vitetta L, Sali S, Isenring L. Ginger as an adjuvant for chemotherapy-induced nausea and vomiting: where does the evidence stand? Asia Pacific Journal of Clinical Oncology 2014;10:115-116.

Schloss J, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L.B complex vitamins reduce the onset and severity of chemotherapy inducedsensory peripheral neuropathy. 7th International Conference and Exhibition on Nutraceuticals and Functional Foods. October 14-17, 2014, Istanbul, Turkey.

Vitetta L. Probiotics, the gastrointestinal tract microbiome and musculoskeletal diseases. International Probiotic Association World Congress. May 9-10, 2014, Athens, Greece. In: Beneficial Microbes 5 (Suppl 1): 23.

Vitetta L. The gastrointestinal tract microbiome and the metabolism of herbal compounds such as trigonella foenum-graecum extract. The 4^th International Symposium on Curry and Spice (April 24, 2014) in Seoul, South Korea.

Page not found

Professor Luis Vitetta

Publications

By Type

By Year

Selected Grants

2018

Conferences